(The 4th CIIE) Depth｜A Look at the "Universal Gravity" of the Chinese Market from the CIIE
China News Service, November 10 (Reporter Li Shuzheng) The first show debut has become the "standard configuration" for participating companies at the CIIE.
The huge stage of 360,000 square meters reflects the "universal gravitation" of the Chinese market.
"We believe that the CIIE is the best stage for the'first product'." said Chris Toth, CEO of Varian Medical Systems.
As a "repeat customer" of the CIIE, Varian brought three major "world premieres" to the 4th CIIE, and even "moved" the ProBeam 360° treatment room, which is comparable to the actual treatment room, into the exhibition site. The cubic meter of "body" has become the largest volume of exhibits in the medical hall.
At the 4th China International Import Expo, Deng & Bai's and Nan Hongqiao held a strategic cooperation framework agreement signing ceremony.
Photo courtesy of Dun & Bradstreet
Why do "returning customers" frequently increase their numbers and choose to make their debut at the CIIE?
One of the reasons is that China has become more attractive as an "accelerator" for high-end manufacturing.
“The CIIE has brought acceleration to the development of Varian.” said Zhang Xiao, senior vice president of Varian Medical and president of Greater China. Since participating in the CIIE for the first time, the output of Varian’s Beijing base has been in three years. An increase of 6 times; 90% of the products are exported to about 60 countries around the world, and exports in 2021 are expected to increase by 40%.
At present, the Beijing base has surpassed the Silicon Valley headquarters in the United States in one fell swoop, becoming the R&D and production base for the most complete product line of Warri Safety Sphere.
"No place in the world can surpass China, so that we can achieve greater victory in the fight against cancer." Tao Kerui said.
As a "driver" for innovative research and development, China's potential has made multinational pharmaceutical companies more eye-catching.
The CIIE promotes international exchanges and encourages innovation and collaboration to attract companies to "show themselves."
At this CIIE, Takeda Pharmaceuticals, the world’s top ten and Asia’s largest multinational pharmaceutical company, released a number of world-first and best-in-class innovative products and breakthrough therapies in the fields of digestion, tumors, rare diseases, and blood products. .
Not long ago, Takeda China Regional Headquarters and Takeda Asian Development Center both "moved" to Pudong, Shanghai.
Varian Medical "moved" the ProBeam 360° treatment room, which is comparable to the actual treatment room, into the CIIE site.
Photo by Li Shuzheng
"We believe that with the new round of expansion and opening up, the Chinese market will usher in a new round of high-quality development driven by innovation, and will be deeply integrated into the construction of the global innovation system to become a leader in global innovation." Takeda China President Shan Guohong said that Takeda will continue to increase its weight in China, and is committed to introducing more innovative drugs and breakthrough therapies into China, and further increasing investment and investment in China's R&D system.
In the past 20 years, China has used data to prove that it is a "top student" in economic "subjects" in the global village: economic aggregate has rushed from sixth to second in the world, and trade in services has risen from eleventh to second in the world. Second place, trade in goods and foreign direct investment has leapt to the top.
"As the country with the largest volume of import and export of goods in the world, the sophistication of China's supply chain system is also on the'commanding heights.'" Bai's "Global Digital Intelligence Supply Chain Solution" will be the world premiere at the 4th CIIE.
Wu Guangyu revealed that this product did not simply choose China as the starting place, but was jointly created by D&B’s teams in multiple countries to achieve "Global Creation as China". "This proves that we take the Chinese market as the most Prioritize the market to consider".
Wu Guangyu said frankly that the era of simply "translating" overseas products to China and hoping for success has passed. "For any multinational company, if it wants to better serve the Chinese market, it must be created for China."
When economic globalization encounters a countercurrent, China’s choice has always been: to support countries around the world in opening up, and to oppose unilateralism and protectionism.
The arrival of the CIIE as scheduled, highlights China's role as a "stabilizer" of global economic and trade.
Xu Chuanhong, a professor at Shanghai University of Engineering Science and Technology and executive director of the China Conference and Exhibition Economic Research Association, pointed out that with the deepening of global integration, behind any worldwide exhibition, there is an invisible international industrial chain as the underlying logic.
"What attracts countries and enterprises to participate actively is actually the direction of globalization." Xu Chuanhong said.
(over)